Equities

Active Biotech AB publ

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Active Biotech AB publ

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)0.0034
  • Today's Change0.000 / 6.25%
  • Shares traded0.00
  • 1 Year change-28.57%
  • Beta0.3805
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.

  • Revenue in SEK (TTM)0.00
  • Net income in SEK-38.50m
  • Incorporated1983
  • Employees5.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.